共 50 条
- [46] Can we learn lessons from the FDA’s approval of aducanumab? Nature Reviews Neurology, 2021, 17 : 715 - 722
- [48] What we can learn from Japan's tsunami experiences AUSTRALIAN JOURNAL OF EMERGENCY MANAGEMENT, 2019, 34 (03): : 21 - 21
- [50] Today’s Challenges in PharmacovigilanceWhat can we Learn from Epoetins? Drug Safety, 2011, 34 : 273 - 287